Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Multiple Myeloma Clinical Trials Near Me

As of November 21, 2026, 549 Multiple Myeloma clinical trials are recruiting now and 157 are not yet recruiting. In the US, 273 of them have at least 1 open site, across 50 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Multiple Myeloma pageCompare treatmentsMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+787 more

All 549 Multiple Myeloma trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
    Most sites in Michigan, Illinois and Minnesota
    RecruitingAges 40-75Alliance for Clinical Trials in Oncology
    616US sites
    43 states
  2. Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
    Most sites in Ohio, Illinois and Michigan
    RecruitingPhase 3Ages 18+ECOG-ACRIN Cancer Research Group
    482US sites
    44 states
  3. Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
    Most sites in Michigan, Illinois and Minnesota
    RecruitingPhase 3SWOG Cancer Research Network
    388US sites
    35 states
  4. Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
    Most sites in Wisconsin, Illinois and Michigan
    RecruitingPhase 3Ages 18+ECOG-ACRIN Cancer Research Group
    303US sites
    33 states
  5. TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
    Most sites in California, Maine and Wisconsin
    RecruitingPhase 2Ages 12+American Society of Clinical Oncology
    145US sites
    28 states
  6. A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Most sites in California, New York and Florida
    RecruitingCenter for International Blood and Marrow Transplant Research
    111US sites
    39 states
  7. MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
    Most sites in Florida, California and Texas
    RecruitingPhase 3Ages 18+Pfizer
    92US sites
    19 states
  8. A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
    Most sites in Ohio, New York and North Carolina
    RecruitingPhase 3Ages 18+Janssen Research & Development
    65US sites
    27 states
  9. A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
    Most sites in New York, California and Texas
    RecruitingPhase 3Ages 18+Janssen Research & Development
    47US sites
    24 states
  10. Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
    Most sites in New York, North Carolina and Ohio
    RecruitingPhase 3Ages 18+AstraZeneca
    44US sites
    23 states
  11. A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
    Most sites in New York, North Carolina and Texas
    RecruitingPhase 3Ages 18-130AstraZeneca
    43US sites
    19 states
  12. Integrated Cancer Repository for Cancer Research
    Most sites in Missouri, Nebraska and Florida
    RecruitingAges 19-110University of Nebraska
    42US sites
    18 states
  13. A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
    Most sites in California, New York and Ohio
    RecruitingPhase 3Ages 18+Janssen Research & Development
    41US sites
    29 states
  14. Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
    Most sites in Florida, New York and Texas
    RecruitingPhase 2Ages 18+Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
    38US sites
    26 states
  15. A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
    Most sites in North Carolina, New York and Texas
    RecruitingPhase 3Ages 18+AstraZeneca
    36US sites
    21 states
  16. A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
    Most sites in Florida, Alabama and New York
    RecruitingPhase 3Ages 18+Pfizer
    34US sites
    8 states
  17. AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
    Most sites in California, Florida and Texas
    RecruitingPhase 1/2Ages 18+AstraZeneca
    33US sites
    19 states
  18. Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
    Most sites in Illinois, Montana and Idaho
    RecruitingPhase 2Ages 18+National Cancer Institute (NCI)
    33US sites
    5 states
  19. A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
    Most sites in Florida, Maryland and North Carolina
    RecruitingPhase 1/2Ages 12+Sumitomo Pharma America
    30US sites
    18 states
  20. A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
    Most sites in Texas, Florida and California
    RecruitingPhase 3Ages 18+GlaxoSmithKline
    30US sites
    19 states
Get an email when Multiple Myeloma trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Multiple Myeloma:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Multiple Myeloma trials in the US, and what stage they are in

Of the 273 Multiple Myeloma trials with a US site, 28 are in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 165 of them. Phase 4 studies of an already approved treatment make up 4. The remaining 76 have no drug phase, such as studies that follow people over time or test a device or a way of giving care. Companies run 84 of them, and universities, hospitals, foundations and government groups run 189. The sponsors with the most are Memorial Sloan Kettering Cancer Center (14), M.D. Anderson Cancer Center (12) and Mayo Clinic (11). The most recently listed one first appeared on ClinicalTrials.gov on November 12, 2026.

Multiple Myeloma trials in the US, state by state

Of the 273 Multiple Myeloma trials with a US site, 19 accept children under 18. Their open sites are in 47 states and Washington, DC, most often Texas, New York and California. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
New York84784New York (68), Commack (15), Harrison (15), plus 25 more
California76676Duarte (25), San Francisco (20), Los Angeles (17), plus 62 more
Texas631063Houston (46), Dallas (22), San Antonio (10), plus 15 more
Florida61561Miami (25), Jacksonville (21), Tampa (18), plus 34 more
North Carolina59459Chapel Hill (26), Charlotte (26), Winston-Salem (18), plus 22 more
Georgia58458Atlanta (50), Augusta (4), Newnan (4), plus 11 more
Massachusetts56456Boston (54), Brighton (1), Holyoke (1), plus 5 more
Ohio52652Columbus (30), Cincinnati (19), Cleveland (18), plus 49 more
New Jersey45445Hackensack (16), Basking Ridge (15), Middletown (15), plus 19 more
Illinois41541Chicago (31), Maywood (6), Peoria (6), plus 52 more
Show the other 41 states
Minnesota38338Rochester (29), Minneapolis (13), Brainerd (5), plus 43 more
Colorado37337Denver (27), Aurora (10), Longmont (5), plus 14 more
Washington35435Seattle (25), Tacoma (9), Edmonds (4), plus 25 more
Michigan34334Detroit (22), Ann Arbor (19), Grand Rapids (11), plus 43 more
Arizona33333Phoenix (21), Gilbert (8), Tucson (5), plus 4 more
Missouri33333St Louis (29), Kansas City (6), Saint Joseph (5), plus 23 more
Tennessee33333Nashville (33), Chattanooga (1), Memphis (1)
Wisconsin33333Milwaukee (26), Madison (12), Green Bay (5), plus 50 more
Utah29529Salt Lake City (28), St. George (2), Cedar City (1), plus 1 more
Maryland27427Baltimore (15), Bethesda (13), Columbia (2), plus 9 more
Pennsylvania27527Philadelphia (20), Pittsburgh (8), Allentown (5), plus 15 more
Alabama24224Birmingham (19), Mobile (4), Daphne (1), plus 2 more
Oregon24524Portland (17), Eugene (6), Bend (3), plus 9 more
Virginia24424Fairfax (9), Richmond (8), Charlottesville (6), plus 11 more
Nebraska23423Omaha (21), Kearney (4), Lincoln (3), plus 4 more
Iowa22322Iowa City (16), Waukee (6), Des Moines (5), plus 12 more
Connecticut20320New Haven (15), Torrington (5), Derby (4), plus 19 more
Indiana19419Indianapolis (13), Fort Wayne (4), Richmond (3), plus 6 more
Kentucky17317Louisville (12), Lexington (6), Bardstown (3), plus 4 more
Kansas15215Westwood (6), Garden City (4), Kansas City (4), plus 8 more
Louisiana13113Baton Rouge (6), Shreveport (5), New Orleans (3), plus 4 more
Arkansas12212Little Rock (8), Fort Smith (4), Springdale (3)
District of Columbia11211Washington D.C. (11)
South Carolina11411Charleston (6), Greenville (4), Greer (3), plus 15 more
Montana818Billings (5), Missoula (5), Bozeman (4), plus 5 more
Rhode Island818Providence (4), Westerly (3), Warwick (1)
North Dakota727Fargo (6), Bismarck (3), Jamestown (3), plus 2 more
Maine616Brewer (3), Augusta (2), Belfast (2), plus 14 more
New Hampshire626Concord (2), Lebanon (2), Manchester (2), plus 3 more
New Mexico626Albuquerque (3), Rio Rancho (3), Las Cruces (2), plus 2 more
Oklahoma636Oklahoma City (6), Tulsa (1)
South Dakota636Sioux Falls (4), Rapid City (2), Aberdeen (1), plus 1 more
West Virginia626Morgantown (4), Charleston (2), Bridgeport (1), plus 3 more
Idaho515Boise (4), Nampa (4), Caldwell (3), plus 6 more
Nevada505Reno (4), Las Vegas (3), Henderson (2), plus 2 more
Alaska414Anchorage (4)
Delaware414Newark (3), Brandywine (1)
Hawaii333Honolulu (3), ‘Ewa Beach (1)
Mississippi212Gulfport (1), Jackson (1)
Vermont202Burlington (2), White River Junction (1)
Wyoming202Cheyenne (2), Cody (1)

US hospitals running the most Multiple Myeloma trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Multiple Myeloma.

  1. Memorial Sloan Kettering Cancer CenterNew York, New York20 trials
  2. Dana-Farber Cancer InstituteBoston, Massachusetts19 trials
  3. Beth Israel Deaconess Medical CenterBoston, Massachusetts14 trials
  4. Colorado Blood Cancer InstituteDenver, Colorado13 trials
  5. Washington University School of MedicineSt Louis, Missouri13 trials
  6. Dana Farber Cancer InstituteBoston, Massachusetts11 trials
  7. Massachusetts General HospitalBoston, Massachusetts11 trials
  8. University of Nebraska Medical CenterOmaha, Nebraska11 trials
  9. M D Anderson Cancer CenterHouston, Texas10 trials
  10. Mayo Clinic in RochesterRochester, Minnesota10 trials

Help getting to a Multiple Myeloma trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Corporate Angel Network
Puts cancer patients in empty seats on business jets for treatment, second opinions and clinical trials. Open to anyone with cancer who can walk and travel without medical help, and it does not check income.
American Cancer Society Hope Lodge
Offers a free place to stay at 31 Hope Lodge locations for people getting cancer treatment far from home. People facing cancer and their caregivers, when treatment is far from home.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Multiple Myeloma trial near you

Are there Multiple Myeloma clinical trials near me?

As of November 21, 2026, 549 Multiple Myeloma clinical trials are recruiting now and 157 are not yet recruiting. In the US, 273 of them have at least 1 open site, across 50 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Multiple Myeloma clinical trial sites?

Recruiting Multiple Myeloma trials list open sites in 50 states and Washington, DC. New York, California and Texas have the most, and the table on this page lists every state.

Are there Multiple Myeloma trials for children near me?

Of the 273 Multiple Myeloma trials with a US site, 19 accept children under 18. Their open sites are in 47 states and Washington, DC, most often Texas, New York and California. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Multiple Myeloma clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights, and Corporate Angel Network flies cancer patients for free.

What if there is no Multiple Myeloma trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Multiple Myeloma trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

FDA-approved for Multiple Myeloma: Abecma (idecabtagene vicleucel), Blenrep (belantamab mafodotin-blmf), Carvykti (ciltacabtagene autoleucel), Darzalex (daratumumab), Elrexfio (elranatamab-bcmm), Empliciti (elotuzumab), Kyprolis (carfilzomib), Lynozyfic (linvoseltamab-gcpt) and 20 more on the disease page.

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 21, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.